跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 78,445 条关于
“anti-PD-(L)1”
全部
78,445
临床试验
46,349
药物
12,109
机构
1,537
资讯
18,450
4年前
Combination Immunotherapies Show Promise in Pancreatic Cancer Treatment
9个月前
BeyondSpring's Plinabulin Shows Consistent Survival Benefit in EGFR Wild-Type NSCLC After Anti-PD-(L)1 Failure
去年
BMS-986253 Fails to Improve Outcomes in Advanced Melanoma Post-PD-1/L1 Therapy
2年前
FDA Approves Genentech's Tecentriq Hybreza, First Subcutaneous Anti-PD-(L)1 Immunotherapy
2年前
FDA Approves Roche's Tecentriq Hybreza, a Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy
去年
Palleon's E-602 Shows Promise in Combination with Cemiplimab for Anti-PD-(L)1 Resistant Solid Tumors
去年
Fianlimab Plus Cemiplimab Shows Durable Activity in Advanced Melanoma
去年
Zai Lab's Tivdak Shows Positive Results in China Subpopulation of Phase 3 Cervical Cancer Trial
去年
Breakthroughs in Non-Small-Cell Lung Cancer Research Highlight New Treatment Pathways
2年前
BioNTech's mRNA Immunotherapy BNT111 Shows Positive Phase 2 Results in Advanced Melanoma
第 1 页,共 1845 页
上一页
下一页